{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:47:52Z","timestamp":1784328472137,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"vor","delay-in-days":266,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.tiv.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T09:14:04Z","timestamp":1428743644000},"page":"987-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models"],"prefix":"10.1016","volume":"29","author":[{"given":"D.","family":"Dias-da-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Arbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2015.04.001_b0005","first-page":"U1959","article-title":"Nephrotoxicity of BZP-based herbal party pills: a New Zealand case report","volume":"119","author":"Alansari","year":"2006","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.tiv.2015.04.001_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Met. Disp."},{"key":"10.1016\/j.tiv.2015.04.001_b0015","first-page":"55","article-title":"\u2018Party pill\u2019 drugs \u2013 BZP and TFMPP","volume":"122","author":"Antia","year":"2009","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.tiv.2015.04.001_b0020","article-title":"Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of \u2018legal high\u2019 packages containing synthetic cathinones","author":"Ara\u00fajo","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","article-title":"Piperazine compounds as drugs of abuse","volume":"122","author":"Arbo","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.tiv.2015.04.001_b0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.toxlet.2014.06.031","article-title":"Piperazine designer drugs induce toxicity in rat cardiomyoblast h9c2 cells through mitochondrial impairment","volume":"229","author":"Arbo","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2015.04.001_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.01.001","article-title":"A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity","volume":"134","author":"Astashkina","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2015.04.001_b0040","first-page":"406","article-title":"Acute psychosis following ingestion of \u2018Rapture\u2019","volume":"12","author":"Austin","year":"2004","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.tiv.2015.04.001_b0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-2001-15702","article-title":"Fatal brain edema after ingestion of ecstasy and benzylpiperazine","volume":"126","author":"Balmelli","year":"2001","journal-title":"DMW"},{"key":"10.1016\/j.tiv.2015.04.001_b0050","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.npp.1300585","article-title":"N-Substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u2018Ecstasy\u2019)","volume":"30","author":"Baumann","year":"2005","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.tiv.2015.04.001_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuro.2012.09.005","article-title":"The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons","volume":"34","author":"Capela","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tiv.2015.04.001_b0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/tx9501750","article-title":"D-Amphetamine interactions with glutathione in freshly isolated rat hepatocytes","volume":"9","author":"Carvalho","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s002040000200","article-title":"Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes","volume":"74","author":"Carvalho","year":"2001","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00204-003-0510-7","article-title":"Hepatotoxicity of 3,4-methylenedioxyamphetamine and \u03b1-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates","volume":"78","author":"Carvalho","year":"2004","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/138920110791591535","article-title":"Mechanisms underlying the hepatotoxic effects of ecstasy","volume":"11","author":"Carvalho","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.tiv.2015.04.001_b0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/474253a","article-title":"Poison in party pills is too much to swallow","volume":"474","author":"Cole","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2015.04.001_b0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","article-title":"Purchasing \u2018legal highs\u2019 on the internet \u2013 is there consistency in what you get?","volume":"103","author":"Davies","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.tiv.2015.04.001_b0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00204-012-0929-9","article-title":"The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?","volume":"87","author":"Dias da Silva","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0100","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.tiv.2013.04.010","article-title":"Cytotoxic effects of amphetamine mixtures in primary hepatocytes are severely aggravated under hyperthermic conditions","volume":"27","author":"Dias da Silva","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2015.04.001_b0105","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00204-013-1082-9","article-title":"An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis","volume":"87","author":"Dias da Silva","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jat.2889","article-title":"Combination effects of amphetamines under hyperthermia \u2013 the role played by oxidative stress","volume":"34","author":"Dias da Silva","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jat.2885","article-title":"Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations","volume":"34","author":"Dias da Silva","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/138920008783331086","article-title":"Cell lines: a tool for in vitro drug metabolism studies","volume":"9","author":"Donato","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2015.04.001_b0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-2004-827175","article-title":"Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile","volume":"37","author":"Feuchtl","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.tiv.2015.04.001_b0135","first-page":"1784","article-title":"Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand","volume":"118","author":"Gee","year":"2005","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.tiv.2015.04.001_b0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/15563651003592948","article-title":"Multiorgan failure from 1-benzylpiperazine ingestion \u2013 legal high or lethal high?","volume":"48","author":"Gee","year":"2010","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004714-199808000-00007","article-title":"Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers","volume":"18","author":"Gijsman","year":"1998","journal-title":"J. Clin. Psycopharmacol."},{"key":"10.1016\/j.tiv.2015.04.001_b0145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.001_b0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(25)12653-0","article-title":"Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct","volume":"254","author":"Hiramatsu","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2015.04.001_b0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FTD.0b013e318170a879","article-title":"Acute chlorophenylpiperazine overdose: a case report and review of the literature","volume":"30","author":"Kovaleva","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.tiv.2015.04.001_b0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00213-010-2081-7","article-title":"Determining the subjective and physiological effects of BZP combined with TFMPP in human males","volume":"214","author":"Lin","year":"2011","journal-title":"Psycopharmacology"},{"key":"10.1016\/j.tiv.2015.04.001_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00204-011-0733-y","article-title":"Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism","volume":"86","author":"Lin","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.toxlet.2009.02.012","article-title":"Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes","volume":"187","author":"Liu","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2015.04.001_b0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin-phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2015.04.001_b0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-200404000-00007","article-title":"Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types","volume":"26","author":"Maurer","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.tiv.2015.04.001_b0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1742-7843.2006.pto_243.x","article-title":"Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats","volume":"98","author":"Meririne","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0076-6879(78)52006-5","article-title":"Isolation and use of liver cells","volume":"52","author":"Mold\u00e9us","year":"1978","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tiv.2015.04.001_b0195","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00204-013-1057-x","article-title":"Update on 1-benzylpiperazine (BZP) party pills","volume":"87","author":"Monteiro","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0200","first-page":"233","article-title":"Drug-induced hepatotoxicity: a review","volume":"02","author":"Pandit","year":"2012","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.001_b0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0887-2333(95)00035-7","article-title":"Molecular mechanism of diclofenac hepatotoxicity: association of cell injury with oxidative metabolism and decrease in ATP levels","volume":"9","author":"Ponsoda","year":"1995","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2015.04.001_b0210","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.tiv.2008.01.010","article-title":"Effect of chronic ethanol exposure on the hepatotoxicity of ecstasy in mice: an ex vivo study","volume":"22","author":"Pontes","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2015.04.001_b0215","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.tiv.2012.12.004","article-title":"Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells","volume":"27","author":"Rodrigues","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2015.04.001_b0220","doi-asserted-by":"crossref","first-page":"C12","DOI":"10.1152\/ajpcell.00314.2006","article-title":"The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly topic","volume":"293","author":"Scatena","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tiv.2015.04.001_b9000","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/etc.5620200228","article-title":"A general best-fit method for concentration-response curves and the estimation of low-effect concentrations","volume":"20","author":"Scholze","year":"2001","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tiv.2015.04.001_b0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jms.556","article-title":"New designer drug 1-(3,4-methylenedioxybenzyl)piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography\/mass spectrometry","volume":"39","author":"Staack","year":"2004","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.tiv.2015.04.001_b0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1389200054021825","article-title":"Metabolism of designer drugs of abuse","volume":"6","author":"Staack","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2015.04.001_b0225","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jms.513","article-title":"New designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP): gas chromatography\/mass spectrometry and liquid chromatography\/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine","volume":"38","author":"Staack","year":"2003","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.tiv.2015.04.001_b0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/00498250310001644544","article-title":"In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step","volume":"34","author":"Staack","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2015.04.001_b0245","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0269881109102608","article-title":"Randomised double-blind, placebo-controlled trial of the effects of the \u2018party pills\u2019 BZP\/TFMPP alone and in combination with alcohol","volume":"24","author":"Thompson","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tiv.2015.04.001_b0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tox.2013.06.009","article-title":"Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity","volume":"311","author":"Tu","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2015.04.001_b0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/dmd.32.6.626","article-title":"Selective inhibition of Cyp2B6-catalyzed bupropion hydroxylation in human liver microssomes in vitro","volume":"32","author":"Turpeinen","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.001_b0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbi.2009.02.012","article-title":"Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels","volume":"180","author":"Usta","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2015.04.001_b0265","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF03161209","article-title":"Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and 1-benzylpiperazine (BZP)","volume":"4","author":"Wood","year":"2008","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.001_b0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pbb.2007.06.007","article-title":"MDMA-like behavioral effects of N-substituted piperazines in the mouse","volume":"88","author":"Yarosh","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tiv.2015.04.001_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(96)03341-0","article-title":"Cocaine-induced mitochondrial dysfunction in primary culture of rat cardiomyocytes","volume":"112","author":"Yuan","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2015.04.001_b0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mam.2008.08.003","article-title":"Glutathione in liver diseases and hepatotoxicity","volume":"30","author":"Yuan","year":"2009","journal-title":"Mol. Aspects Med."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233315000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233315000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:49:24Z","timestamp":1747910964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233315000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0887233315000697"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2015.04.001","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}